The core activity of DRAC AG is the licensing, marketing and distribution of medicinal products for the treatment of life-threatening and rare diseases on the Swiss market. The company also offers supporting services such as Regulatory Affairs, Pharmacovigilance and Quality Management.
AI-generated
Offering
Products & services
Industry:Wholesale - Health & Cosmetic Products
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Services as a Marketing Authorisation Holder for partner companies: temporary or long-term MAH representation, wholesale and distribution, import, storage, market release, and marketing in Switzerland and Liechtenstein.
Support Services
Support Services for third-party companies and customers from the pharmaceutical industry: Regulatory Affairs, quality management, audits, Swissmedic inspections, pharmacovigilance, Medical Clearing, pricing and reimbursement, and legal support.
Medicines
Medicines available in Switzerland, including Kuvan, Kaliumiodid 65 SERB, Firdapse, Naglazyme, Sunosi, and Vimizim.
Knowledge
No knowledge articles yet
Once DRAC AG has claimed this profile, we'll publish editorial articles and case studies here together.